Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

The Court of International Trade on Wednesday directed Customs and Border Protection to remove defunct tariffs when finalizing non-liquidated entries.

CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

Buying Gleamer will expand the capabilities RadNet acquired through the DeepHealth buyout in 2020, particularly in X-ray, and ...

Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.

Medical device lobbyists called for more staffing transparency in user fee negotiations with the Food and Drug Administration ...

Keith Evans, general manager of Stryker’s Mako and enabling technologies unit, said the handheld robot will be in a limited release for the first half of 2026.

The startup is seeking regulatory approval in Europe and the U.S. for the device, which restored vision to patients with late-stage macular degeneration in a small clinical trial.

With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.